✦ LIBER ✦

Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone

✍ Scribed by H. A. El-Masri; Russell S. Thomas; G. Rob Sabados; Jenny K. Phillips; Alexander A. Constan; Stephen A. Benjamin; Melvin E. Andersen; Harihara M. Mehendale; Raymond S. H. Yang

Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 288 KB
Volume: 70
Category: Article
ISSN: 0340-5761
DOI: 10.1007/s002040050331

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Physiologically based pharmacokinetic mo

Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog

✍ Frans G. M. Russel; Alfons C. Wouterse; Cees A. M. Van Ginneken 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

Plasma kinetics and renal excretion of iodopyracet (3\*0g, adminstered i.v.) with and without concomitant administration of probenecid were studied in the beagle dog. Pharmacokinetic analysis revealed that tubular secretion is the predominant route of excretion, and that secretion is inhibited by pr

Utility of a physiologically–based pharm

Utility of a physiologically–based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug–drug–disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice

✍ Joseph A. Grillo; Ping Zhao; Julie Bullock; Brian P. Booth; Min Lu; Kathy Robie- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Background: Rivaroxaban is an oral Factor Xa inhibitor. The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment are co-administered with another drug that is both a P-gp and a moderate CYP3A4

Semi-mechanistic Pharmacokinetic/Pharmac

Semi-mechanistic Pharmacokinetic/Pharmacodynamic Modelling of the Antinociceptive Response in the Presence of Competitive Antagonism: The Interaction Between Tramadol and its Active Metabolite on μ-Opioid Agonism and Monoamine Reuptake Inhibition, in the Rat

✍ Horst Beier; María J. Garrido; Thomas Christoph; Dirk Kasel; Iñaki F. Trocóniz 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 409 KB

Investigation of 5-FU disposition after

Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model

✍ Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Tohru Ishikawa; Hideo Ishits 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

## Abstract The nonlinear pharmacokinetics of capecitabine, a triple prodrug of 5‐FU preferentially activated in tumour tissues, was investigated in human cancer xenograft models. A physiologically based pharmacokinetic (PBPK) model integrating the activation process of capecitabine to 5‐FU and 5‐F